HSRMF yields 666.67% · MRK yields 2.76%● Live data
📍 HSRMF pulled ahead of the other in Year 1
Combined, HSRMF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HSRMF + MRK for your $10,000?
Hastings Technology Metals Limited engages in the exploration and development of rare earth deposits in Australia. The company focuses on neodymium and praseodymium minerals. Its flagship project is the Yangibana Rare Earths Project, which holds 100% interests in 6 mining leases, 2 prospecting licenses, 11 exploration licenses, 5 general purpose leases, and 13 miscellaneous licenses; and 70% interests in 3 mining leases, 8 exploration licenses, and 2 general purpose leases that covers an area of 650 sq km area located in the Gascoyne region of Western Australia. The company was formerly known as Hastings Rare Metals Limited and changed its name to Hastings Technology Metals Limited in October 2015. Hastings Technology Metals Limited was incorporated in 2006 and is based in Perth, Australia.
Full HSRMF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.